Management Board Contact Us An innovative life sciences platform transforming the future of healthcare LifeSci Acquisition II Corporation, a Special Purpose Acquisition Company, Sponsored by an Affiliate of LifeSci Partners, Announces the Acquisition of Science 37, Inc. View Our Prospectus Management Team Andrew McDonald Chief Executive Officer Michael Rice Chief Operating Officer David Dobkin Chief Financial Officer Matthew Margiotta Vice President Bob Spivak Vice President Board of Directors • Thomas Wynn • Thomas Mathers • Graham Walmsley • Scott Janssen • Elizabeth Barrett About Science37 To learn more about Science37, please visit science37.com/ Press Release Science 37 to Become Publicly Listed via Merger with LifeSci Acquisition II Corp., Powering the Clinical Trial Operating System of the Future Presentations Corporate Overview Investors NASDAQ: LSAQ 5d 1m 3m 6m 1y 2y 5y 10y SEC PROSPECTUS (424B4) Contact 250 West 55th St. Suite 3401 New York, NY 10019 investment@lifesciacquisition.com Name Email Message SEND © 2020 LifeSci Acquisition II Corp. All rights reserved. Privacy Policy